Fortis Healthcare Limited (NSE:FORTIS)
India flag India · Delayed Price · Currency is INR
916.80
+5.50 (0.60%)
Aug 20, 2026, 3:15 PM IST

Fortis Healthcare Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
95,06291,27877,82868,92962,97657,176
Revenue Growth
17.50%17.28%12.91%9.45%10.14%41.87%
Cost of Revenue
38,60736,19732,00529,23939,89424,923
Gross Profit
56,45455,08245,82339,69023,08232,253
Selling, General & Admin
4,2894,2894,1523,4173,0842,265
Other Operating Expenses
30,97230,06525,88723,6918,99719,340
Operating Expenses
39,96038,84833,89530,53415,23924,650
Operating Income
16,49416,23411,9279,1567,8447,603
Interest Expense
-2,813-2,704-1,444-936.01-985.87-1,194
Interest & Investment Income
394.31394.31598.35298.94238.29215.48
Earnings From Equity Investments
178.12163.52115.2395.1218.4241.47
Currency Exchange Gain (Loss)
2.062.06-7.54-3.64154.615.9
Other Non Operating Income (Expenses)
-256.13-246.83-262.29-228.25-178.43-188.94
EBT Excluding Unusual Items
14,00013,84310,9278,3837,2916,693
Impairment of Goodwill
------123.11
Gain (Loss) on Sale of Investments
19.7319.732.583.817.4-
Gain (Loss) on Sale of Assets
18.4418.4434.8735.02169.0835.22
Asset Writedown
---393.78---
Legal Settlements
-0.17-0.17-0.35-1.9-4.35-0.53
Other Unusual Items
-253.43-222.43-499.58160.17736.13,273
Pretax Income
13,78513,65810,0708,5808,1999,878
Income Tax Expense
3,0833,0171,9772,1271,8691,978
Earnings From Continuing Operations
10,70210,6428,0946,4526,3307,899
Net Income to Company
10,70210,6428,0946,4526,3307,899
Minority Interest in Earnings
-223.24-224.14-351.69-463.44-442.5-2,348
Net Income
10,47910,4187,7425,9895,8875,551
Net Income to Common
10,47910,4187,7425,9895,8875,551
Net Income Growth
20.65%34.56%29.28%1.72%6.05%-
Shares Outstanding (Basic)
755755755755755755
Shares Outstanding (Diluted)
755755755755755755
Shares Change
0.01%-----
EPS (Basic)
13.8813.8010.267.937.807.35
EPS (Diluted)
13.8813.8010.267.937.807.35
EPS Growth
20.64%34.56%29.32%1.69%6.10%-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-6,5595,7701,5763,7506,499
Free Cash Flow Per Share
-8.697.642.094.978.61
Dividend Per Share
-1.0001.0001.0001.000-
Dividend Growth
-0%0%0%--
Gross Margin
59.39%60.35%58.88%57.58%36.65%56.41%
Operating Margin
17.35%17.79%15.32%13.28%12.46%13.30%
Profit Margin
11.02%11.41%9.95%8.69%9.35%9.71%
Free Cash Flow Margin
-7.19%7.41%2.29%5.96%11.37%
EBITDA
20,15819,77414,97711,83210,3699,956
EBITDA Margin
21.20%21.66%19.24%17.17%16.46%17.41%
D&A For EBITDA
3,6633,5413,0502,6762,5252,353
EBIT
16,49416,23411,9279,1567,8447,603
EBIT Margin
17.35%17.79%15.32%13.28%12.46%13.30%
Effective Tax Rate
22.36%22.09%19.63%24.80%22.80%20.03%
Revenue as Reported
95,55991,78578,49769,31263,59457,449